You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Kaposiform Lymphangiomatosis

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphatic Malformation, Generalized Lymphatic Anomaly (GLA), Central Conducting Lymphatic Anomaly Trial in Boston

Recruiting
  • Lymphatic Malformation
  • +9 more
    • Boston, Massachusetts
      Boston Children's Hospital
    Sep 8, 2022

    A Prospective Natural History Study of Lymphatic Anomalies

    Recruiting
    • Lymphatic Diseases
    • Lymphatic Abnormalities
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 22, 2023

      Hemangioma, Kaposiform Hemangioendothelioma Trial in Shanghai (Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2))

      Completed
      • Hemangioma
      • Kaposiform Hemangioendothelioma
      • Shanghai, China
        Children's Hospital of Fudan University
      Jan 27, 2023

      Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma Trial in Chengdu (Tacrolimus ointment)

      Recruiting
      • Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
      • Tacrolimus ointment
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Jan 15, 2023

      Hemangioendothelioma Trial in Chengdu (Sirolimus)

      Recruiting
      • Hemangioendothelioma
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      May 1, 2022

      Kaposiform Hemangioendothelioma Trial in Chengdu (Sirolimus)

      Recruiting
      • Kaposiform Hemangioendothelioma
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Apr 6, 2022

      Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)

      Recruiting
      • Kaposiform Hemangioendothelioma
      • Kasabach-Merritt Syndrome
      • Shanghai, Shanghai, China
        Children's Hospital of Fudan University
      Oct 21, 2022

      Sirolimus on Immunizations During Treatment of Kaposiform

      Recruiting
      • Kaposiform Hemangioendothelioma
        • Shanghai, Shanghai, China
          Children's Hospital of Fudan University
        Apr 22, 2022

        Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP) Trial in Shanghai (prednison and Sirolimus,

        Not yet recruiting
        • Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
        • Shanghai, Shanghai, China
          Shanghai Children's Medical Center Shanghai Jiaotong University
        Jun 5, 2020

        Kaposiform Hemangioendothelioma (KHE), Kasabach-Merritt Syndrome, Tufted Angioma Trial in United States (Vincristine, Sirolimus)

        Terminated
        Has Results
        • Kaposiform Hemangioendothelioma (KHE)
        • +2 more
        • Palo Alto, California
        • +6 more
        May 20, 2021

        Gorham Disease, Lymphatic Diseases, Lymphangiomatosis Trial in Philadelphia (Dynamic Contrast Enhanced Magnetic Resonance

        Completed
        • Gorham Disease
        • +2 more
        • Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL)
        • +2 more
        • Philadelphia, Pennsylvania
          Children's Hospital of Philadelphia
        Mar 19, 2018

        Kaposiform Hemangioendotheliomas, Tufted Angioma, Capillary Venous Lymphatic Malformation Trial in Boston, Cincinnati

        Unknown status
        • Kaposiform Hemangioendotheliomas
        • +8 more
        • Boston, Massachusetts
        • +1 more
        Feb 3, 2015